SUTRO BIOPHARMA, INC. (STRO) Operating cash flow 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$177.2MFY2025 · since FY2016: -$13.2M → -$177.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$177.2M | +7.5% |
| FY2024 | -$191.5M | -71.6% |
| FY2023 | -$111.6M | -3245.0% |
| FY2022 | $3.5M | +104.3% |
| FY2021 | -$81.7M | -20.5% |
| FY2020 | -$67.8M | -4.3% |
| FY2019 | -$65.0M | -612.7% |
| FY2018 | $12.7M | +134.2% |
| FY2017 | -$37.1M | -181.9% |
| FY2016 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STRO financial trends
STRO RevenueSTRO Net incomeSTRO Net marginSTRO Gross profitSTRO Gross marginSTRO Operating incomeSTRO Operating marginSTRO Free cash flowSTRO Capital expendituresSTRO Return on equitySTRO Stock buybacksSTRO Dividends paidSTRO Total assetsSTRO Total liabilitiesSTRO Shareholders’ equitySTRO overview →